ILLUMINA INC: directors' dealings · United States · SEC (Form 4) Explore the full directors' dealings record of ILLUMINA INC, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €26.3bn. The latest transaction was filed on 16 February 2016 (Levée d'options). Among the most active insiders: FLATLEY JAY T. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 16 February 2016
All Executives47 Thresholds0 Prospectus0 Other0
Declarations 47 total
◇ Director · Executives · 12 Feb 2016
3,750 shares Common Stock SEC:0001127602-16-041475:0
▼ Director · Executives · 12 Feb 2016
3,750 shares Common Stock SEC:0001127602-16-041475:1
▼ EVP Ops, Products, Strategy · Executives · 1 Feb 2016
1,108 shares Common Stock SEC:0001127602-16-039383:0
● Chief Executive Officer · Executives · 1 Feb 2016
1,762 shares Common Stock SEC:0001127602-16-039179:0
● Chief Executive Officer · Executives · 1 Feb 2016
1,032 shares Common Stock SEC:0001127602-16-039179:1
● Sr. VP, Human Resources · Executives · 29 Jan 2016
449 shares Common Stock SEC:0001127602-16-038830:0
● Sr. VP, Human Resources · Executives · 29 Jan 2016
221 shares Common Stock SEC:0001127602-16-038830:1
● Chief Accounting Officer · Executives · 29 Jan 2016
548 shares Common Stock SEC:0001127602-16-038834:0
● Chief Accounting Officer · Executives · 29 Jan 2016
247 shares Common Stock SEC:0001127602-16-038834:1
● Sr VP & General Counsel · Executives · 29 Jan 2016
255 shares Common Stock SEC:0001127602-16-038836:0
● EVP & Chief Commercial Officer · Executives · 29 Jan 2016
527 shares Common Stock SEC:0001127602-16-038838:0
● EVP & Chief Commercial Officer · Executives · 29 Jan 2016
265 shares Common Stock SEC:0001127602-16-038838:1
● Sr VP, Chief Medical Officer · Executives · 29 Jan 2016
253 shares Common Stock SEC:0001127602-16-038840:0
● Sr VP, Corporate Development · Executives · 29 Jan 2016
447 shares Common Stock SEC:0001127602-16-038842:0
● Sr VP, Corporate Development · Executives · 29 Jan 2016
221 shares Common Stock SEC:0001127602-16-038842:1
● EVP Clinical Genomics · Executives · 29 Jan 2016
529 shares Common Stock SEC:0001127602-16-038844:0
● EVP Clinical Genomics · Executives · 29 Jan 2016
265 shares Common Stock SEC:0001127602-16-038844:1
● EVP Ops, Products, Strategy · Executives · 29 Jan 2016
444 shares Common Stock SEC:0001127602-16-038848:0
● EVP Ops, Products, Strategy · Executives · 29 Jan 2016
265 shares Common Stock SEC:0001127602-16-038848:1
● Sr VP & CTO · Executives · 29 Jan 2016
448 shares Common Stock SEC:0001127602-16-038852:0
● EVP & Chief Administrative Ofc · Executives · 29 Jan 2016
696 shares Common Stock SEC:0001127602-16-038856:0
● EVP & Chief Administrative Ofc · Executives · 29 Jan 2016
367 shares Common Stock SEC:0001127602-16-038856:1
● Sr VP & CTO · Executives · 29 Jan 2016
221 shares Common Stock SEC:0001127602-16-038852:1
◆ Director · Executives · 27 Jan 2016
6,588 shares Common Stock SEC:0001127602-16-038615:0
◇ Chief Executive Officer · Executives · 26 Jan 2016
20,000 shares Common Stock SEC:0001127602-16-038283:0
25 of 47 declarations
Load more (22 remaining)